ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-61.5%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | -93.3% |
| 2024 | 0.00 | -67.4% |
| 2023 | 0.00 | +163.0% |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |